Market Overview

Caleres Q4 Earnings Preview

Share:

On Tuesday, Caleres (NYSE: CAL) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Earnings and Revenue

Caleres earnings will be near 44 cents per share on sales of $695.6 million, according to analysts.

Caleres earnings in the same period a year ago were 33 cents. Quarterly sales came in at $639.48 million. The analyst consensus estimate would represent a 33.33 percent increase in the company's EPS figure. Revenue would be up 8.78 percent on a year-over-year basis.

Here's how the company's reported EPS has compared to analyst estimates in the past:

 

Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate 0.86 0.45 0.39 0.38
EPS Actual 0.8 0.48 0.4 0.33

 

Stock Performance

Over the last 52-week period, shares are down 8.09 percent. Given that these returns are generally negative, long-term shareholders are probably upset going into this earnings release.

Over the past 90 days, analysts have adjusted their estimates higher for EPS and revenues. The average rating by analysts on Caleres stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

Caleres is scheduled to hold a conference call at 4:30 p.m. ET and it can be accessed here: http://investor.caleres.com/news/events

Posted-In: Earnings News Previews Trading Ideas

 

Related Articles (CAL)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Earnings Outlook For Enzo Biochem

24 Stocks Moving In Tuesday's Pre-Market Session